ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.56
+0.08 (1.46%)
May 20, 2025, 4:00 PM - Market closed
ImmuCell Employees
As of December 31, 2024, ImmuCell had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees decreased by 4 or -5.06% compared to the previous year.
Employees
75
Change (1Y)
-4
Growth (1Y)
-5.06%
Revenue / Employee
$364,037
Profits / Employee
-$3,624
Market Cap
49.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ICCC News
- 5 days ago - ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 8 days ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 6 weeks ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - GlobeNewsWire
- 6 weeks ago - ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® - GlobeNewsWire
- 2 months ago - ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire